This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen-Levy, Z
Right arrow Articles by Cleary, M L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen-Levy, Z
Right arrow Articles by Cleary, M L

 Previous Article  |  Next Article 

Mol Cell Biol. 1989 February; 9(2): 701-710

The bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation.

Z Chen-Levy, J Nourse and M L Cleary

Department of Pathology, Stanford University School of Medicine, California 94305.

ABSTRACT

We have identified a 24-kilodalton protein that is the product of the human bcl-2 gene, implicated as an oncogene because of its presence at the site of t(14;18) translocation breakpoints. The Bcl-2 protein was detected by specific, highly sensitive rabbit antibodies and was shown to be present in a number of human lymphoid cell lines and tissues, as well as in mouse B cells transfected with a bcl-2 cDNA construct. Characterization of the Bcl-2 protein demonstrated that it has a lipophilic nature and is associated with membrane structures, probably by means of its hydrophobic carboxy-terminal membrane-spanning domain. In t(14;18)-carrying cell lines, the protein is predominantly localized to the perinuclear endoplasmic reticulum, with a minor fraction in the plasma membrane. These properties, together with the observations that Bcl-2 does not have a characteristic signal peptide and is not glycosylated, suggest that it is an integral-membrane protein that spans the bilayer at its C-terminal hydrophobic region but is exposed only at the cytoplasmic surface. The relative abundance of the Bcl-2 protein in various human lymphoid cell lines correlated with transcription of the bcl-2 gene. The protein was abundant in all t(14;18)-carrying cell lines and lymphomas and was also found at lower levels in pre-B-cell lines and nonmalignant lymphoid tissues that do not carry t(14;18) translocations. These results suggest that the Bcl-2 protein is functional in normal B lymphocytes and that a quantitative difference in its expression may play a role in the pathogenesis of lymphomas carrying the t(14;18) translocation.


Mol Cell Biol. 1989 February; 9(2): 701-710




This article has been cited by other articles:

  • Szegezdi, E., MacDonald, D. C., Ni Chonghaile, T., Gupta, S., Samali, A. (2009). Bcl-2 family on guard at the ER. Am. J. Physiol. Cell Physiol. 296: C941-C953 [Abstract] [Full Text]  
  • Ou, L., Wu, Y., Ip, C., Meng, X., Hsu, Y.-C., Ip, M. M. (2008). Apoptosis induced by t10,c12-conjugated linoleic acid is mediated by an atypical endoplasmic reticulum stress response. J. Lipid Res. 49: 985-994 [Abstract] [Full Text]  
  • Reed, J. C. (2008). Bcl-2-family proteins and hematologic malignancies: history and future prospects. Blood 111: 3322-3330 [Abstract] [Full Text]  
  • Wilson-Annan, J., O'Reilly, L. A., Crawford, S. A., Hausmann, G., Beaumont, J. G., Parma, L. P., Chen, L., Lackmann, M., Lithgow, T., Hinds, M. G., Day, C. L., Adams, J. M., Huang, D. C.S. (2003). Proapoptotic BH3-only proteins trigger membrane integration of prosurvival Bcl-w and neutralize its activity. JCB 162: 877-888 [Abstract] [Full Text]  
  • Bevilacqua, A., Ceriani, M. C., Canti, G., Asnaghi, L., Gherzi, R., Brewer, G., Papucci, L., Schiavone, N., Capaccioli, S., Nicolin, A. (2003). Bcl-2 Protein Is Required for the Adenine/Uridine-rich Element (ARE)-dependent Degradation of Its Own Messenger. J. Biol. Chem. 278: 23451-23459 [Abstract] [Full Text]  
  • Barrans, S. L., Evans, P. A. S., O'Connor, S. J. M., Kendall, S. J., Owen, R. G., Haynes, A. P., Morgan, G. J., Jack, A. S. (2003). The t(14;18) Is Associated with Germinal Center-derived Diffuse Large B-Cell Lymphoma and Is a Strong Predictor of Outcome. Clin. Cancer Res. 9: 2133-2139 [Abstract] [Full Text]  
  • Denis, G. V., Yu, Q., Ma, P., Deeds, L., Faller, D. V., Chen, C.-Y. (2003). Bcl-2, via Its BH4 Domain, Blocks Apoptotic Signaling Mediated by Mitochondrial Ras. J. Biol. Chem. 278: 5775-5785 [Abstract] [Full Text]  
  • Nutt, L. K., Pataer, A., Pahler, J., Fang, B., Roth, J., McConkey, D. J., Swisher, S. G. (2002). Bax and Bak Promote Apoptosis by Modulating Endoplasmic Reticular and Mitochondrial Ca2+ Stores. J. Biol. Chem. 277: 9219-9225 [Abstract] [Full Text]  
  • Morris, M. J., Tong, W. P., Cordon-Cardo, C., Drobnjak, M., Kelly, W. K., Slovin, S. F., Terry, K. L., Siedlecki, K., Swanson, P., Rafi, M., DiPaola, R. S., Rosen, N., Scher, H. I. (2002). Phase I Trial of BCL-2 Antisense Oligonucleotide (G3139) Administered by Continuous Intravenous Infusion in Patients with Advanced Cancer. Clin. Cancer Res. 8: 679-683 [Abstract] [Full Text]  
  • Kingham, B. F., Zelnik, V., Kopácek, J., Majerciak, V., Ney, E., Schmidt, C. J. (2001). The genome of herpesvirus of turkeys: comparative analysis with Marek's disease viruses. J. Gen. Virol. 82: 1123-1135 [Abstract] [Full Text]  
  • Hsu, S. Y., Hsueh, A. J. W. (2000). Tissue-Specific Bcl-2 Protein Partners in Apoptosis: An Ovarian Paradigm. Physiol. Rev. 80: 593-614 [Abstract] [Full Text]  
  • Ray, R., Chen, G., Vande Velde, C., Cizeau, J., Park, J. H., Reed, J. C., Gietz, R. D., Greenberg, A. H. (2000). BNIP3 Heterodimerizes with Bcl-2/Bcl-XL and Induces Cell Death Independent of a Bcl-2 Homology 3 (BH3) Domain at Both Mitochondrial and Nonmitochondrial Sites. J. Biol. Chem. 275: 1439-1448 [Abstract] [Full Text]  
  • Hogarth, L. A., Hall, A. G. (1999). Increased BAX Expression Is Associated With an Increased Risk of Relapse in Childhood Acute Lymphocytic Leukemia. Blood 93: 2671-2678 [Abstract] [Full Text]  
  • Froesch, B. A., Aime-Sempe, C., Leber, B., Andrews, D., Reed, J. C. (1999). Inhibition of p53 Transcriptional Activity by Bcl-2 Requires Its Membrane-anchoring Domain. J. Biol. Chem. 274: 6469-6475 [Abstract] [Full Text]  
  • Hsu, S. Y., Hsueh, A. J. W. (1998). A Splicing Variant of the Bcl-2 Member Bok with a Truncated BH3 Domain Induces Apoptosis but Does Not Dimerize with Antiapoptotic Bcl-2 Proteins in Vitro. J. Biol. Chem. 273: 30139-30146 [Abstract] [Full Text]  
  • Ichimiya, M., Chang, S. H., Liu, H., Berezesky, I. K., Trump, B. F., Amstad, P. A. (1998). Effect of Bcl-2 on oxidant-induced cell death and intracellular Ca2+ mobilization. Am. J. Physiol. Cell Physiol. 275: C832-C839 [Abstract] [Full Text]  
  • Nishikawa, M., Takeda, K., Sato, E. F., Kuroki, T., Inoue, M. (1998). Nitric oxide regulates energy metabolism and Bcl-2 expression in intestinal epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 274: G797-G801 [Abstract] [Full Text]  
  • Moffatt, S., Yaegashi, N., Tada, K., Tanaka, N., Sugamura, K. (1998). Human Parvovirus B19 Nonstructural (NS1) Protein Induces Apoptosis in Erythroid Lineage Cells. J. Virol. 72: 3018-3028 [Abstract] [Full Text]  
  • Wolter, K. G., Hsu, Y.-T., Smith, C. L., Nechushtan, A., Xi, X.-G., Youle, R. J. (1997). Movement of Bax from the Cytosol to Mitochondria during Apoptosis. JCB 139: 1281-1292 [Abstract] [Full Text]  
  • Garland, J. M., Halestrap, A. (1997). Energy Metabolism during Apoptosis. bcl-2 PROMOTES SURVIVAL IN HEMATOPOIETIC CELLS INDUCED TO APOPTOSE BY GROWTH FACTOR WITHDRAWAL BY STABILIZING A FORM OF METABOLIC ARREST. J. Biol. Chem. 272: 4680-4688 [Abstract] [Full Text]  
  • Linnik, M. D., Zahos, P., Geschwind, M. D., Federoff, H. J. (1995). Expression of bcl-2 From a Defective Herpes Simplex Virus–1 Vector Limits Neuronal Death in Focal Cerebral Ischemia. Stroke 26: 1670-1675 [Abstract] [Full Text]  
  • Sakuragi, N., Matsuo, H., Coukos, G., Furth, E. E., Bronner, M. P., VanArsdale, C. M., Krajewsky, S., Reed, J. C., Strauss, J. F. (1994). Differentiation-Dependent Expression of the BCL-2 Proto-Oncogene in the Human Trophoblast Lineage. Reproductive Sciences 1: 164-172 [Abstract]  
  • Gonzalez-Garcia, M, Perez-Ballestero, R, Ding, L, Duan, L, Boise, L., Thompson, C., Nunez, G (1994). bcl-XL is the major bcl-x mRNA form expressed during murine development and its product localizes to mitochondria. Development 120: 3033-3042 [Abstract]  
  • Lu, Q., Hanby, A., Nasser Hajibagheri, M., Gschmeissner, S., Lu, P., Taylor-Papadimitriou, J, Krajewski, S, Reed, J., Wright, N. (1994). Bcl-2 protein localizes to the chromosomes of mitotic nuclei and is correlated with the cell cycle in cultured epithelial cell lines. J. Cell Sci. 107: 363-371 [Abstract]  
  • Merry, D., Veis, D., Hickey, W., Korsmeyer, S. (1994). bcl-2 protein expression is widespread in the developing nervous system and retained in the adult PNS. Development 120: 301-311 [Abstract]  
  • Raff, M., Barres, B., Burne, J., Coles, H., Ishizaki, Y, Jacobson, M. (1993). Programmed cell death and the control of cell survival: lessons from the nervous system. Science 262: 695-700 [Abstract]